MedElevator
Войти в исследования Frontiers in veterinary science · 2026
Comparative evaluation of trimethoprim-sulfonamide ratios and synergistic interactions against porcine respiratory pathogens.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mag Patrik, Klein Ulrich, Depondt Wouter, Piross Imre Sándor, Tóth Réka, Somogyi Zoltán, Kovács Dóra, Kerek Ádám, Jerzsele Ákos
Аннотация
INTRODUCTION: Potentiated sulfonamides are widely used in the treatment of porcine respiratory disease complex, but their synergistic activity depends on pathogen-related and pharmacodynamic factors, including the trimethoprim-to-sulfonamide ratio. This study aimed to systematically evaluate the effect of different ratios on in vitro antibacterial interactions against major porcine respiratory pathogens.
METHODS: Trimethoprim was combined with sulfamethoxazole, sulfachloropyridazine, or sulfadiazine at four mass ratios (1:5, 1:10, 1:19, 1:40). Minimum inhibitory concentrations were determined using broth microdilution according to CLSI guidelines. Drug interactions were quantified using the fractional inhibitory concentration index, and a linear mixed-effects model was applied to assess the effects of bacterial species, compound combination, and ratio.
RESULTS: The strongest and most consistent synergistic activity was observed at the 1:5 ratio across most pathogen-drug combinations. Increasing the proportion of the sulfonamide generally reduced synergism and occasionally resulted in antagonistic interactions, particularly in Glaesserella parasuis. Differences between sulfonamides were limited, although sulfachloropyridazine showed higher intrinsic activity against Actinobacillus pleuropneumoniae and G. parasuis, and greater efficacy in combination with trimethoprim against Pasteurella multocida. Statistical analysis confirmed significant effects of both drug ratio and combination on interaction outcomes.
DISCUSSION: These findings demonstrate that synergism between trimethoprim and sulfonamides is strongly ratio-dependent and cannot be reliably characterized using a single fixed ratio. Ratio-specific evaluation may therefore support more rational antimicrobial use in veterinary medicine.
METHODS: Trimethoprim was combined with sulfamethoxazole, sulfachloropyridazine, or sulfadiazine at four mass ratios (1:5, 1:10, 1:19, 1:40). Minimum inhibitory concentrations were determined using broth microdilution according to CLSI guidelines. Drug interactions were quantified using the fractional inhibitory concentration index, and a linear mixed-effects model was applied to assess the effects of bacterial species, compound combination, and ratio.
RESULTS: The strongest and most consistent synergistic activity was observed at the 1:5 ratio across most pathogen-drug combinations. Increasing the proportion of the sulfonamide generally reduced synergism and occasionally resulted in antagonistic interactions, particularly in Glaesserella parasuis. Differences between sulfonamides were limited, although sulfachloropyridazine showed higher intrinsic activity against Actinobacillus pleuropneumoniae and G. parasuis, and greater efficacy in combination with trimethoprim against Pasteurella multocida. Statistical analysis confirmed significant effects of both drug ratio and combination on interaction outcomes.
DISCUSSION: These findings demonstrate that synergism between trimethoprim and sulfonamides is strongly ratio-dependent and cannot be reliably characterized using a single fixed ratio. Ratio-specific evaluation may therefore support more rational antimicrobial use in veterinary medicine.